Abstract
Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive disorder of variable presentation caused by the deficiency of the 3β- hydroxycholesterol Δ 7- reductase. Over the past 10 years, our biochemical laboratory has screened 191 plasma samples for possible SLOS, measuring the plasma cholesterol and 7-dehydrocholesterol using gas chromatography-mass spectrometry (GC-MS). The SLOS was confirmed in only five Arab patients with growth retardation, global developmental delay, dysmorphic features, and 2-3 toe syndactyly, among other findings. All cases represented moderate to severe form of SLOS. One patient had a unique cardiovascular malformation (cor triatriatum with significant obstruction of the right pulmonary veins). Two previously reported N287K (861 C>A) and R352Q (1055 G>A) and a novel R352L (1055 G>T) mutations were identified in the DHCR7 gene in these patients. The paper sheds light on this rare disease among Arabs and reviews all reported SLOS cases in the Arab population. © 2011 John Wiley & Sons A/S.
Author supplied keywords
Cite
CITATION STYLE
Al-Owain, M., Imtiaz, F., Shuaib, T., Edrees, A., Al-Amoudi, M., Sakati, N., … Al-Aama, J. Y. (2012). Smith-Lemli-Opitz syndrome among Arabs. Clinical Genetics, 82(2), 165–172. https://doi.org/10.1111/j.1399-0004.2011.01742.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.